High concentrations of DCA inhibit the ISC differentiation into goblet and Paneth cells, which is prevented by YAP1 antibody. A The mRNA expression levels of Atoh1, Elf3, Gfi1 and Sox9 in mouse ileum tissue (n = 3 or 5). B Representative micrographs of intestinal enteroids in four groups after 96 h of culture in mice. Scale bars: 200 μm. C Line graph of changes in enteroids budding rates at 24, 48, 72 and 96 h (n = 3–6). D Comparison of enteroids budding rates at 24, 48, 72 and 96 h (n = 3–6). E Representative micrographs of mouse intestinal enteroids treated with or without DCA. Scale bars: 200 μm. F Line graph of changes in enteroids budding rates after DCA intervention with 24, 48 h (n = 5). G Comparison of enteroids budding rates after DCA intervention with 24, 48 h (n = 5). H Representative micrographs of human intestinal enteroids treated with or without DCA. Scale bars: 100 μm. I Line graph of changes in human enteroids budding rates after DCA intervention with 24, 48 and 72 h (n = 5). J Comparison of human enteroids budding rates after DCA intervention with 24, 48 and 72 h (n = 5). K Representative micrographs of immunofluorescence staining for MUC2 in mouse intestinal enteroids. Scale bars: 200 μm. L Quantitative analysis of K (n = 4). M Representative micrographs of immunofluorescence staining for lysozyme in mouse intestinal enteroids. Scale bars: 200 μm. N Quantitative analysis of M (n = 4). O Representative micrographs of immunofluorescence staining for MUC2 in human intestinal enteroids. Scale bars: 100 μm. P Quantitative analysis of O (n = 4). Q Representative micrographs of immunofluorescence staining for lysozyme in human intestinal enteroids. Scale bars: 100 μm. R Quantitative analysis of Q (n = 4). S Protein expression of goblet cell marker KRT18 in the terminal ileum of Yap1fl/fl mice and Yap1fl/fl Vil1-Cre mice after 24 h coculture with 100 μM DCA or DMSO (n = 5 or 3). T In vitro culture of human ileal tissue, the mRNA levels of MUC2, LYZ, and DEFA5 were assessed in human ileum tissue with various treatments (n = 3 or 4). DCA, deoxycholic acid; LFD, low-fat diet; HFD, high-fat diet; CHO, cholestyramine. *P < 0.05, **P < 0.01, ***P < 0.001